Approval · Notice of Compliance 1742 · 2001
CLARICID: Notice of Compliance 1742
Issued December 21, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1742
- Date
- December 21, 2001
- Company
- Toba Pharma Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CLARICID | 02245063 | — |
| CLARICID | 02245064 | — |
| CLARICID | 02245065 | — |
| CLARICID | 02245066 | — |
Medicinal ingredients
- CLARITHROMYCIN 125 MG per 5ML
- CLARITHROMYCIN 250 MG per 5ML
- CLARITHROMYCIN 250 MG per TAB
- CLARITHROMYCIN 500 MG per TAB